Cargando…

A Prospective Feasibility Trial to Challenge Patient–Derived Pancreatic Cancer Organoids in Predicting Treatment Response

SIMPLE SUMMARY: Pancreatic cancer (PC) is characterized by an exceptionally aggressive tumor biology, high inter- and intratumor heterogeneity, and resistance to conventional chemotherapy, targeted agents, and immunotherapy. With its rising incidence and dismal prognosis, PC is projected to become t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Beutel, Alica K., Schütte, Lena, Scheible, Jeanette, Roger, Elodie, Müller, Martin, Perkhofer, Lukas, Kestler, Annika M. T. U., Kraus, Johann M., Kestler, Hans A., Barth, Thomas F. E., Lemke, Johannes, Kornmann, Marko, Ettrich, Thomas J., Gout, Johann, Seufferlein, Thomas, Kleger, Alexander
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8196829/ https://www.ncbi.nlm.nih.gov/pubmed/34064221 http://dx.doi.org/10.3390/cancers13112539

Ejemplares similares

Maintenance Therapy for ATM-Deficient Pancreatic Cancer by Multiple DNA Damage Response Interferences after Platinum-Based Chemotherapy
por: Roger, Elodie, et al.
Publicado: (2020)

Pancreatic Ductal Organoids React Kras Dependent to the Removal of Tumor Suppressive Roadblocks
por: Perkhofer, Lukas, et al.
Publicado: (2019)

DNA damage repair as a target in pancreatic cancer: state-of-the-art and future perspectives
por: Perkhofer, Lukas, et al.
Publicado: (2021)

Functional Genomic Screening During Somatic Cell Reprogramming Identifies DKK3 as a Roadblock of Organ Regeneration
por: Arnold, Frank, et al.
Publicado: (2021)

Precision medicine meets the DNA damage response in pancreatic cancer
por: Perkhofer, Lukas, et al.
Publicado: (2018)

Serum IgG4 levels outperform IgG4/IgG RNA ratio in differential diagnosis of IgG4-related disease
por: Schulte, Lucas A., et al.
Publicado: (2020)

Targeting DNA Damage Repair Mechanisms in Pancreas Cancer
por: Perkhofer, Lukas, et al.
Publicado: (2021)

Self-Expandable Metal Stents for Persisting Esophageal Variceal Bleeding after Band Ligation or Injection-Therapy: A Retrospective Study
por: Müller, Martin, et al.
Publicado: (2015)

YAP Activation Drives Liver Regeneration after Cholestatic Damage Induced by Rbpj Deletion
por: Tharehalli, Umesh, et al.
Publicado: (2018)

Comparative Panel Sequencing of DNA Variants in cf-, ev- and tumorDNA for Pancreatic Ductal Adenocarcinoma Patients
por: Waldenmaier, Mareike, et al.
Publicado: (2022)

A highly efficient multi-core algorithm for clustering extremely large datasets
por: Kraus, Johann M, et al.
Publicado: (2010)

Significantly improved precision of cell migration analysis in time-lapse video microscopy through use of a fully automated tracking system
por: Huth, Johannes, et al.
Publicado: (2010)

Synergistic targeting and resistance to PARP inhibition in DNA damage repair-deficient pancreatic cancer
por: Gout, Johann, et al.
Publicado: (2021)

Enteropathogenic Infections: Organoids Go Bacterial
por: Hentschel, Viktoria, et al.
Publicado: (2021)

Comparative gene-expression profiling of the large cell variant of gastrointestinal marginal-zone B-cell lymphoma
por: Barth, Thomas F. E., et al.
Publicado: (2017)

A Blood-Based Multi Marker Assay Supports the Differential Diagnosis of Early-Stage Pancreatic Cancer
por: Berger, Andreas W., et al.
Publicado: (2019)

The Impact of Biomarkers in Pancreatic Ductal Adenocarcinoma on Diagnosis, Surveillance and Therapy
por: Sturm, Niklas, et al.
Publicado: (2022)

A Follow-Up Study of a European IgG4-Related Disease Cohort Treated with Rituximab
por: Backhus, Johanna, et al.
Publicado: (2021)

IFN-γ treatment protocol for MHC-I(lo)/PD-L1(+) pancreatic tumor cells selectively restores their TAP-mediated presentation competence and CD8 T-cell priming potential
por: Stifter, Katja, et al.
Publicado: (2020)

CDKN2A-Mutated Pancreatic Ductal Organoids from Induced Pluripotent Stem Cells to Model a Cancer Predisposition Syndrome
por: Merkle, Jessica, et al.
Publicado: (2021)

Digitalization of adverse event management in oncology to improve treatment outcome—A prospective study protocol
por: Kestler, Angelika M. R., et al.
Publicado: (2021)

TBX3 is dynamically expressed in pancreatic organogenesis and fine-tunes regeneration
por: Melzer, Michael Karl, et al.
Publicado: (2023)

Differentiation of human pluripotent stem cells into pancreatic duct-like organoids
por: Breunig, Markus, et al.
Publicado: (2021)

Neoadjuvant plus adjuvant or only adjuvant nab-paclitaxel plus gemcitabine for resectable pancreatic cancer - the NEONAX trial (AIO-PAK-0313), a prospective, randomized, controlled, phase II study of the AIO pancreatic cancer group
por: Ettrich, Thomas J., et al.
Publicado: (2018)

Nal-IRI with 5-fluorouracil (5-FU) and leucovorin or gemcitabine plus cisplatin in advanced biliary tract cancer - the NIFE trial (AIO-YMO HEP-0315) an open label, non-comparative, randomized, multicenter phase II study
por: Perkhofer, L., et al.
Publicado: (2019)

A fluorescent reporter for mapping cellular protein-protein interactions in time and space
por: Moreno, Daniel, et al.
Publicado: (2013)

Systemic Therapy for Metastatic Pancreatic Cancer
por: Ettrich, Thomas J., et al.
Publicado: (2021)

Targeted deep sequencing of circulating tumor DNA in metastatic pancreatic cancer
por: Berger, Andreas W., et al.
Publicado: (2017)

Treatment monitoring in metastatic colorectal cancer patients by quantification and KRAS genotyping of circulating cell-free DNA
por: Berger, Andreas W., et al.
Publicado: (2017)

Gallbladder Cancer: Current Multimodality Treatment Concepts and Future Directions
por: Sturm, Niklas, et al.
Publicado: (2022)

Homologous recombination deficiency is inversely correlated with microsatellite instability and identifies immunologically cold tumors in most cancer types
por: Budczies, Jan, et al.
Publicado: (2022)

TraqBio - Flexible Progress Tracking for Core Unit Projects
por: Völkel, Gunnar, et al.
Publicado: (2016)

Drug Inhibition of SARS-CoV-2 Replication in Human Pluripotent Stem Cell–Derived Intestinal Organoids
por: Krüger, Jana, et al.
Publicado: (2020)

Functional Genomic Screening in Human Pluripotent Stem Cells Reveals New Roadblocks in Early Pancreatic Endoderm Formation
por: Krüger, Jana, et al.
Publicado: (2022)

Liquid biopsy: an examination of platelet RNA obtained from head and neck squamous cell carcinoma patients for predictive molecular tumor markers
por: Huber, Lisa T., et al.
Publicado: (2023)

Electrocardiographic and cardiac magnetic resonance imaging parameters as predictors of a worse outcome in patients with idiopathic dilated cardiomyopathy
por: Hombach, Vinzenz, et al.
Publicado: (2009)

A systems biology approach to define mechanisms, phenotypes, and drivers in PanNETs with a personalized perspective
por: Werle, Silke D., et al.
Publicado: (2023)

VennMaster: Area-proportional Euler diagrams for functional GO analysis of microarrays
por: Kestler, Hans A, et al.
Publicado: (2008)

Single-cell profiling of GP2-enriched pancreatic progenitors to simultaneously create acinar, ductal, and endocrine organoids
por: Merz, Sarah, et al.
Publicado: (2023)

Patient Empowerment During the COVID-19 Pandemic by Ensuring Safe and Fast Communication of Test Results: Implementation and Performance of a Tracking System
por: Völkel, Gunnar, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_1h97erj6upd6e9oo0rgtntnh4p